JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Different CO2 laser vaporization protocols for the therapy of oral precancerous lesions and precancerous conditions: a 10-year follow-up.

Use of the CO(2) laser (λ = 10.6 μm, continuous wave, defocused) is an established procedure for the treatment of premalignant lesions. Through employment of the sp-mode as well as scanners, thermal laser effects can be reduced but, on the other hand, a lesser degree of destruction of dysplastic cells could lead to an increased recurrence rate. The purpose of this study was to prospectively evaluate the recurrence rates resulting from different methods of CO(2) laser vaporization. From May 1995 to May, 2005, 145 patients with a total of 148 premalignant lesions of the oral mucosa were treated in a prospective clinical study. Sixty-two lesions in 62 patients were vaporized with the defocused CO(2) laser (group 1). In a further 45 lesions (43 patients, group 2), a scanner was additionally employed. In the remaining 41 lesions (40 patients, group 3), vaporization was carried out in the sp-mode in which the scanner was also used. In September, 2005, recurrence rates in the three groups were evaluated. Use of the scanner in sp-mode resulted in the most irregular tissue vaporization. This can be accounted for by the irregular paths of the laser beam and the pulsed delivery of the laser energy. Statistically significant lowest recurrence rates were yielded by the defocused cw-technique followed by the cw-scanner and the sp-mode. These results indicate that for CO(2) laser treatment of premalignant lesions of the oral mucosa, the best results can be achieved with the defocused technique. It may be assumed that other methods with lesser penetration of thermal effects (e.g. sp, scanner) do not reach the deeper-lying cells and, consequently, render higher rates of recurrence.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app